Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › ALKEM

ALKEM

Alkem Laboratories Limited
Mid-capPharma ↗

What the six lenses say about ALKEM — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹5648.5
2026-07-10
VWAP · 1Y anchor
₹5449
+3.7% from VWAP
P/E · TTM
29.3×
TTM EPS ₹192.5
52-week range
79%
position low→high
RSI(14)
65
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How ALKEM’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
9.5
avg conviction decile
Leadership
1/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD995›

The actual numbers

Price vs VWAP (1y)+3.7%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+3.7%
Price vs 50-EMA+3.5%
RSI(14)65
RS vs Nifty 500 · 3M+0.5%
RS vs sector · 3M-11.9%
52-week range79%
Volume vs 30d avg0.53×
Volume vs 60d avg0.69×
ATR(14) · volatility124.8
Bollinger width · vol contraction0.084
FundamentalD868›

The actual numbers

Return on equity (ROE)18.9%
Return on capital (ROCE)21.2%
Operating margin20.6%
Net margin16.0%
Revenue growth · YoY+13.5%
EPS growth · YoY+6.3%
Debt / equity0.15×

Full 8-quarter history in the financials table below.

ValuationD626›

The actual numbers

P/E (TTM)29.3×
TTM EPS₹192.5
52-week range79%
CatalystD853›

The actual numbers

Earnings & momentum52
Capital actions32
Governance151

Every filing in the corporate-announcements panel below.

FlowD1060›

The actual numbers

Promoter holding51.2%
Delivery · 30d avg51.5%
Up/down-day asymmetry2.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D9 + D10 ) ÷ 2 = 9.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
92
Conviction score 92/100 · avg-decile strength 9.5/10
Conviction score92/100›
TechnicalD9›
FundamentalD8›
ValuationD6›
CatalystD8›
FlowD10›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.4pp
+3.6pp
+3.4pp
+4.2pp
+4.1pp
+24.8pp
Nifty 500
Broad-market baseline
+0.0pp
+3.5pp
+2.8pp
+0.5pp
-0.9pp
+21.0pp
Sector
Own-sector index
—
—
+0.4pp
-11.9pp
-15.3pp
+3.1pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

ALKEM daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
5648.50+42.50

Relative strength

RS vs baseline · rebased to 100

ALKEM ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
107.60+0.00

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)3,0323,4153,3743,1443,3714,0013,7373,603
↳ change QoQ—+12.6%-1.2%-6.8%+7.2%+18.7%-6.6%-3.6%
EBITDA (₹cr)729887852391739921828517
EBITDA margin24.0%26.0%25.3%12.4%21.9%23.0%22.2%14.3%
PAT (₹cr)550702641322668779653251
↳ change QoQ—+27.6%-8.7%-49.7%+107.5%+16.6%-16.2%-61.6%
Net margin18.1%20.6%19.0%10.2%19.8%19.5%17.5%7.0%
EPS (₹)45.6057.6052.3425.5855.5663.9953.1919.78
D/E————————
YoY growth · Mar '26Revenue +14.6% YoYPAT -22.0% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 15 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 1 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 28 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 28 May '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 May '26
    LOWgovernance
    Action(s) initiated or orders passed
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds ALKEM

Mutual funds holding ALKEM (10)

FundWeightAUM ₹crGrade
HDFC Mid Cap Gr1.79%97,350
Nippon India Growth Mid Cap Dir Bns1.32%49,169
Nippon India Growth Md Cp Reg Gr Bns1.32%49,169
Nippon India Growth Md Cp Reg Gr PlGrOpt1.32%49,169
SBI Large & Midcap Reg Gr2.01%40,850
Axis Midcap Gr0.87%32,852
ICICI Pru Large & Mid Cap Gr2.01%30,147
HDFC Large and Mid Cap Gr0.60%28,515
DSP Midcap Reg Gr1.80%19,673
HDFC Multi Cap Reg Gr1.26%19,581

ETFs holding ALKEM (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF3.52%
DSP Nifty Healthcare ETF3.10%
Aditya BSL Nifty Healthcare ETF3.10%
Axis NIFTY Healthcare ETF3.10%
ICICI Pru Nifty Healthcare ETF3.00%
Mirae Asset Nifty 500 Healthcare ETF2.55%
Motilal Oswal BSE Healthcare ETF2.19%
Kotak Nifty Midcap 50 ETF1.45%
Groww Nifty 500 Low Volatility 50 ETF1.29%
LIC MF Nifty Midcap 100 ETF0.97%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma